Clinical trials
Phase 3 Virus Diseases trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medicago | 2 |
| Pfizer | 2 |
| AstraZeneca | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
| Janssen R&D Ireland | 1 |
| Janssen-Cilag International NV | 1 |
| ModernaTX, Inc. | 1 |
| Novartis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Virus Diseases | 11 |
| Infections | 5 |
| RNA Virus Infections | 5 |
| Respiratory Tract Infections | 5 |
| COVID-19 | 3 |
| Coronavirus Infections | 3 |
| Lung Diseases | 3 |
| Respiratory Tract Diseases | 3 |
| Hepatitis | 2 |
| Hepatitis C | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.